I had the pleasure of joining Theodoros Mavridis @TheodorosMavri2 and Mira Katan on the EANcast @EANeurology to discuss ESUS. We explored covert embolic sources, atrial cardiomyopathy, PFO closure, biomarkers, and recent trials. #Stroke #ESUS https://t.co/3ANtw5ldTW ⬇️

🎙️ New #EANcast! Ep.175: Acute Ischemic Stroke – Evolving Guidelines & Clinical Decisions I speak with @CatarinaACF about: ⚡ Extended thrombolysis windows and broader reperfusion eligibility 🩺 Thrombectomy in low ASPECTS, mild deficits 🎧 Listen here:

🎙️ New #EANcast episode! I speak with Prof. @DavidSeiffge about Breakthrough Stroke. We cover: 🔍 Diagnostic pitfalls 🧠 Competing mechanisms 🧪 Factor XI inhibitors 🫀 LAA closure 🔬 Ongoing trials + future strategies 🎧 Listen here:

🗺️WSO Spotlight Session 📆4th December 🕒3:30-4:30pm CET 👉Join us for an interactive session on the diagnosis and management of CAA More info and registration here 👇 https://t.co/vhNF4owUgn

Honoured to serve as faculty at #WSC2025 in Barcelona. Proud to present on LAAO for ICH survivors with AF and to chair the Thrombolysis & Thrombectomy highlights session. Inspired by brilliant colleagues and meaningful science pushing stroke care forward. 🧠 #Stroke #Neurology

We’re joining others around the world from #TUH to raise awareness #FAST signs of stroke — because acting quickly can save lives. 👉 Face drooping 👉 Arm weakness 👉 Speech difficulty 👉 Time to call emergency services #WorldStrokeDay @WorldStrokeOrg @ESOstroke @HSELive

⏱️ #WorldStrokeDay – every minute counts.Every 2 seconds, someone has a #stroke. Delay = loss of brain, loss of life. 👉Facial weakness 👉Arm weakness 👉Slurred speech Recognition & #ActFAST save lives. https://t.co/81uqud3JJf #StrokeActionNow @WorldStrokeOrg @WStrokeCampaign

🩸🧠Cerebral Amyloid Angiopathy: Pillars for management #WSC2025 🔖 Read our full Guidelines on behalf of the @iCAAassociation & @WorldStrokeOrg via @IntJStroke 🔗 https://t.co/DJ9WvsiO3s #WSC2025 #NeuroTwitter #stroke #Neurology #neuropath #stroke #dementia #Alzheimers

🚨 New Expert Review on Refractory Migraine When migraine doesn’t respond to even the most advanced treatments, what’s next? Read our new article “Steps to manage treatment-refractory migraine in adults” 👉 https://t.co/XcHIuKFK0A #Migraine #Headache #RefractoryMigraine

Honoured to speak at the WSC2025 in Barcelona. Looking to forward to meeting you all there... Save the date for the next World Stroke Congress which will be held in Barcelona, Spain, October 22-24! https://t.co/GKsvoMDFka #WSC2025 #StrokePrevention #Stroke #StrokeResearch

🌍 Join the 5th @WorldStrokeOrg @ESOstroke GAINS Early Career Investigators Workshop at #WSC2025 in Barcelona! 🕐 Oct 22 | 13:00–16:30 💡 Interactive sessions, mentorship & trial concept presentations 👉 Learn more: https://t.co/FvZ5UjtfHy #StrokeResearch #EarlyCareer #ESOTA

🫀 AFib + prior brain bleed 🧠 or CAA? 🚨New meta-analysis (14 studies, 1,235 pts) finds LAAO may be safe: ✅ Stroke ~2% ✅ Recurrent bleed ~2% ✅ Major bleed ~3% ⚠️ Evidence low — RCTs needed! #StrokePrevention #AFib #LAAO @a_charidimou

Just Accepted! 🌎🧠A Scientific Statement from the International CAA Association and the World Stroke Organization 🧠Diagnosis and Management of Cerebral Amyloid Angiopathy Read it here!👇 https://t.co/esd55jLiNl

Just Accepted! 🌎🧠A Scientific Statement from the International CAA Association and the World Stroke Organization 🧠Diagnosis and Management of Cerebral Amyloid Angiopathy Read it here!👇 https://t.co/esd55jLiNl

🆕 New Publication Can anticoagulant choice protect your kidneys? 🧠🩸 Our systematic review & meta-analysis shows that DOACs delay renal function decline in patients with atrial fibrillation compared to VKAs. 📖 Read the full open-access article: https://t.co/TXbJfg4zZn

Excited to present our newly published study/meta-analysis on LAAO in patients with previous ICrH and/or CAA. Many thanks to my mentor @a_charidimou. Without his guidance this endeavor would not be possible. I also want to thank Dr Archontakis-Barakakis and Dr Chlorogiannis...

New Insights on Migraine Prevention! A fresh analysis comparing Gepants, anti-CGRP monoclonal antibodies, and traditional preventives reveals a clearer picture of benefit vs. risk in migraine care. Click the link below to learn more...

#MondayTip 📊Pooled INTERACT data ✅Intensive BP lowering improves recovery in ICH ⏱️When started <3h (cutoff: 2.6h)➡️reduces haematoma growth ☝️Greatest benefit in mild–moderate ICH (ICH score) 🚨Early treatment improves outcomes👉supports CODE-ICH systems & future trial design

Technical skills are important to influence the patient outcome. 👫 Strokecare is teamwork. Bastian Volbers from @inselgruppe demonstrating how simulation training can improve #stroketreatment. #EAN2025 #simulation #strokecare

I’m honoured to be running for IHS Trustee! I’m passionate about raising awareness and improving headache education, locally and globally. I’d be truly grateful for your support if you are eligible to vote (emails automatically sent) — and please feel free to share this post!